| Primary |
| Blood Cholesterol Increased |
43.1% |
| Hyperlipidaemia |
16.5% |
| Hypercholesterolaemia |
8.1% |
| Blood Cholesterol |
6.6% |
| Hypertension |
3.9% |
| Product Used For Unknown Indication |
3.3% |
| Blood Pressure Increased |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Dyslipidaemia |
2.4% |
| Diabetes Mellitus |
2.1% |
| Low Density Lipoprotein Increased |
1.5% |
| Blood Triglycerides Increased |
1.2% |
| Hypothyroidism |
1.2% |
| Mental Disorder |
1.2% |
| Coronary Artery Disease |
0.9% |
| Pain |
0.9% |
| Atrial Fibrillation |
0.6% |
| Blood Cholesterol Abnormal |
0.6% |
| Cardiac Disorder |
0.6% |
| Cerebrovascular Accident Prophylaxis |
0.6% |
|
| Rhabdomyolysis |
23.4% |
| Myalgia |
19.2% |
| Pain In Extremity |
10.2% |
| Vision Blurred |
5.4% |
| Muscular Weakness |
4.2% |
| Pain |
4.2% |
| Vomiting |
4.2% |
| Amyotrophic Lateral Sclerosis |
3.0% |
| Medication Error |
3.0% |
| Muscle Spasms |
3.0% |
| Drug Interaction |
2.4% |
| Neuropathy Peripheral |
2.4% |
| Pharmaceutical Product Complaint |
2.4% |
| Rash |
2.4% |
| Back Pain |
1.8% |
| Dyspnoea |
1.8% |
| Musculoskeletal Pain |
1.8% |
| Myopathy |
1.8% |
| Myositis |
1.8% |
| Nightmare |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
41.6% |
| Blood Cholesterol Increased |
12.8% |
| Drug Use For Unknown Indication |
10.0% |
| Hypertension |
9.1% |
| Hyperlipidaemia |
4.4% |
| Mental Disorder |
2.9% |
| Diabetes Mellitus |
2.8% |
| Blood Cholesterol |
2.5% |
| Hypercholesterolaemia |
1.8% |
| Type Iia Hyperlipidaemia |
1.4% |
| Blood Cholesterol Abnormal |
1.3% |
| Hypothyroidism |
1.3% |
| Somatoform Disorder |
1.2% |
| Arthritis |
1.1% |
| Depression |
1.1% |
| Pain |
1.1% |
| Blood Triglycerides Increased |
0.9% |
| Cardiac Disorder |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Neuralgia |
0.9% |
|
| Myalgia |
12.9% |
| Completed Suicide |
11.9% |
| Muscle Spasms |
9.0% |
| Rhabdomyolysis |
7.5% |
| Poisoning |
6.0% |
| Toxicity To Various Agents |
6.0% |
| Drug Hypersensitivity |
5.5% |
| Tremor |
5.5% |
| Urticaria |
4.5% |
| Death |
3.5% |
| Drug Ineffective |
3.5% |
| Liver Function Test Abnormal |
3.5% |
| Staphylococcal Sepsis |
3.5% |
| Amyotrophic Lateral Sclerosis |
2.5% |
| Blood Glucose Increased |
2.5% |
| Cardiac Arrest |
2.5% |
| Drug Interaction |
2.5% |
| Drug Toxicity |
2.5% |
| Malaise |
2.5% |
| Pain In Extremity |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.9% |
| Drug Use For Unknown Indication |
15.5% |
| Hypertension |
10.6% |
| Blood Cholesterol Increased |
6.4% |
| Diabetes Mellitus |
5.0% |
| Depression |
3.6% |
| Pain |
3.4% |
| Rheumatoid Arthritis |
3.0% |
| Type 2 Diabetes Mellitus |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Atrial Fibrillation |
2.3% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Osteoporosis |
2.2% |
| Anxiety |
2.0% |
| Blood Cholesterol |
1.8% |
| Prophylaxis |
1.7% |
| Smoking Cessation Therapy |
1.6% |
| Asthma |
1.6% |
| Cardiac Disorder |
1.6% |
| Multiple Myeloma |
1.4% |
|
| Vomiting |
11.1% |
| Weight Decreased |
10.6% |
| Weight Increased |
8.2% |
| Drug Ineffective |
6.9% |
| Nausea |
5.6% |
| Flushing |
5.5% |
| Pain |
5.5% |
| Myocardial Infarction |
4.5% |
| Pruritus |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
| Dyspnoea |
4.4% |
| Tremor |
4.1% |
| Pneumonia |
3.6% |
| Rash |
3.4% |
| Pain In Extremity |
3.1% |
| Death |
3.1% |
| Blood Glucose Increased |
3.1% |
| Vision Blurred |
3.1% |
| Somnolence |
2.7% |
| Urinary Tract Infection |
2.7% |
|
| Interacting |
| Hypertension |
10.5% |
| Drug Use For Unknown Indication |
9.6% |
| Diabetes Mellitus |
8.8% |
| Blood Cholesterol Increased |
7.0% |
| Cardiac Disorder |
7.0% |
| Hypercholesterolaemia |
7.0% |
| Smoking Cessation Therapy |
7.0% |
| Nervous System Disorder |
5.3% |
| Prostate Cancer |
5.3% |
| Wolff-parkinson-white Syndrome |
4.4% |
| Chronic Hepatitis |
3.5% |
| Dyslipidaemia |
3.5% |
| Dyspnoea |
3.5% |
| Insomnia |
3.5% |
| Renal Failure Chronic |
3.5% |
| Thrombocytopenia |
3.5% |
| Blood Cholesterol |
1.8% |
| Blood Pressure |
1.8% |
| Chest Pain |
1.8% |
| Gastrointestinal Disorder |
1.8% |
|
| Rhabdomyolysis |
33.3% |
| Drug Interaction |
13.3% |
| Dizziness Postural |
6.7% |
| Extrasystoles |
6.7% |
| Off Label Use |
6.7% |
| Aspartate Aminotransferase Increased |
3.3% |
| Cardiac Flutter |
3.3% |
| Coma |
3.3% |
| Drug Ineffective |
3.3% |
| Oedema Mouth |
3.3% |
| Swollen Tongue |
3.3% |
| Therapeutic Response Decreased |
3.3% |
| Tooth Loss |
3.3% |
| Urine Colour Abnormal |
3.3% |
| Vision Blurred |
3.3% |
|
